SpyBiotech
Accelerating vaccine development with protein superglues
Creating safe, effective vaccines, fast, is a global health priority.
SpyBiotech, co-founded by Professors Sumi Biswas and Mark Howarth, developed SpyTag/SpyCatcher: a proprietary protein ‘superglue’ that enables stable, rapid assembly of vaccine components. Their platform supports next-generation vaccines for infectious diseases with the potential to reach more people, more quickly.
Sector
Life Sciences
Stage
- Series A